These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 31739402)

  • 1. Inhibition of the Adenosinergic Pathway in Cancer Rejuvenates Innate and Adaptive Immunity.
    Azambuja JH; Ludwig N; Braganhol E; Whiteside TL
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31739402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting adenosine in cancer immunotherapy: a review of recent progress.
    Whiteside TL
    Expert Rev Anticancer Ther; 2017 Jun; 17(6):527-535. PubMed ID: 28399672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Adenosine in Cancer Immunotherapy to Enhance T-Cell Function.
    Vigano S; Alatzoglou D; Irving M; Ménétrier-Caux C; Caux C; Romero P; Coukos G
    Front Immunol; 2019; 10():925. PubMed ID: 31244820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting adenosinergic pathway and adenosine A
    Abouelkhair MA
    Med Hypotheses; 2020 Nov; 144():110012. PubMed ID: 32590324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Immune Regulatory Role of Adenosine in the Tumor Microenvironment.
    Xing J; Zhang J; Wang J
    Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenosine signaling and the immune system: When a lot could be too much.
    Antonioli L; Fornai M; Blandizzi C; Pacher P; Haskó G
    Immunol Lett; 2019 Jan; 205():9-15. PubMed ID: 29702147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purinergic signaling during intestinal inflammation.
    Longhi MS; Moss A; Jiang ZG; Robson SC
    J Mol Med (Berl); 2017 Sep; 95(9):915-925. PubMed ID: 28547076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the adenosine signaling pathway in macrophages for cancer immunotherapy.
    Yang H; Zhang Z; Zhao K; Zhang Y; Yin X; Zhu G; Wang Z; Yan X; Li X; He T; Wang K
    Hum Immunol; 2024 May; 85(3):110774. PubMed ID: 38521664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Canonical and non-canonical adenosinergic pathways.
    Ferretti E; Horenstein AL; Canzonetta C; Costa F; Morandi F
    Immunol Lett; 2019 Jan; 205():25-30. PubMed ID: 29550257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoregulatory activity of adenosine and its role in human cancer progression.
    Muller-Haegele S; Muller L; Whiteside TL
    Expert Rev Clin Immunol; 2014 Jul; 10(7):897-914. PubMed ID: 24871693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting purinergic pathway to enhance radiotherapy-induced immunogenic cancer cell death.
    Bao X; Xie L
    J Exp Clin Cancer Res; 2022 Jul; 41(1):222. PubMed ID: 35836249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The adenosinergic machinery in cancer: In-tandem insights from basic mechanisms to therapy.
    Kang C; Liu L; Wu C; Li L; Jia X; Xie W; Chen S; Wu X; Zheng H; Liu J; Li R; Zeng B
    Front Immunol; 2023; 14():1111369. PubMed ID: 36911717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular ATP and Adenosine in Cancer Pathogenesis and Treatment.
    Chiarella AM; Ryu YK; Manji GA; Rustgi AK
    Trends Cancer; 2021 Aug; 7(8):731-750. PubMed ID: 34074623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenosinergic signaling as a target for natural killer cell immunotherapy.
    Wang J; Matosevic S
    J Mol Med (Berl); 2018 Sep; 96(9):903-913. PubMed ID: 30069747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific Activation of A3, A2A and A1 Adenosine Receptors in CD73-Knockout Mice Affects B16F10 Melanoma Growth, Neovascularization, Angiogenesis and Macrophage Infiltration.
    Koszałka P; Gołuńska M; Urban A; Stasiłojć G; Stanisławowski M; Majewski M; Składanowski AC; Bigda J
    PLoS One; 2016; 11(3):e0151420. PubMed ID: 26964090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular adenosine triphosphate and adenosine in cancer.
    Stagg J; Smyth MJ
    Oncogene; 2010 Sep; 29(39):5346-58. PubMed ID: 20661219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenosine can thwart antitumor immune responses elicited by radiotherapy : Therapeutic strategies alleviating protumor ADO activities.
    Vaupel P; Multhoff G
    Strahlenther Onkol; 2016 May; 192(5):279-87. PubMed ID: 26961686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular ATP and adenosine: The Yin and Yang in immune responses?
    Faas MM; Sáez T; de Vos P
    Mol Aspects Med; 2017 Jun; 55():9-19. PubMed ID: 28093236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune cell regulation by autocrine purinergic signalling.
    Junger WG
    Nat Rev Immunol; 2011 Mar; 11(3):201-12. PubMed ID: 21331080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of tumor infiltrated innate immune cells by adenosine.
    Strakhova R; Cadassou O; Cros-Perrial E; Jordheim LP
    Purinergic Signal; 2020 Sep; 16(3):289-295. PubMed ID: 32529478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.